The Cochrane Library, 14 Dec 2018 Adding docetaxel to hormone therapy probably improves survival for people with metastatic hormone-sensitive prostate cancer but…
Cochrane UK, 27 Nov 2018 Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer CD012816 http://bit.ly/2Qja5ua